Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Malignant Lymphoma |
Free Subscription
1 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
Clinicopathologic features and survival outcomes of CD30 expression in extranodal
natural killer/T-cell lymphoma.
Am J Clin Pathol. 2024 Feb 22:aqae012. doi: 10.1093.
PubMed
Abstract available
TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas:
Implications for Targeted Therapy.
Am J Surg Pathol. 2024;48:337-352.
PubMed
Abstract available
Lymphoma immunotherapy: the garden of forking paths.
Blood. 2024;143:655-657.
PubMed
Flower cell morphology in high-grade B-cell lymphoma of the maxillary sinus.
Blood. 2024;143:738.
PubMed
Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell
lymphoma.
Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093.
PubMed
Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort
study.
Br J Dermatol. 2024;190:432-434.
PubMed
Noninvasive minimal residual disease assessment in relapsed/refractory large
B-cell lymphoma using digital droplet PCR.
Eur J Haematol. 2024 Feb 18. doi: 10.1111/ejh.14191.
PubMed
Abstract available
Infection epidemiology in relation to different therapy phases in patients with
haematological malignancies receiving CAR T-cell therapy.
Eur J Haematol. 2024;112:371-378.
PubMed
Abstract available
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab
induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.283918.
PubMed
Abstract available
TP53 DNA binding domain mutational status and rituximab-based treatment are
independent prognostic factors for pediatric Burkitt lymphoma patients
stratification.
Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284868.
PubMed
Abstract available
Selective pharmacologic targeting of CTPS1 shows single-agent activity and
synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.
Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284345.
PubMed
Abstract available
LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion and
contributes to rituximab resistance in diffuse large B-cell lymphoma.
J Biol Chem. 2024 Feb 15:105762. doi: 10.1016/j.jbc.2024.105762.
PubMed
Abstract available
Immunochemotherapy triggered reversible cerebral vasoconstriction syndrome in a
patient with intravascular large B-cell lymphoma.
Leuk Lymphoma. 2024 Feb 22:1-4. doi: 10.1080/10428194.2024.2316252.
PubMed
Potential genetic mechanisms driving B/myeloid conversion in patients with
follicular lymphoma and Langerhans cell neoplasms.
Leuk Lymphoma. 2024 Feb 21:1-5. doi: 10.1080/10428194.2024.2319691.
PubMed
Abstract available
Effect of atorvastatin versus placebo on efficacy in patients with diffuse large
B-cell lymphoma receiving R-CHOP.
Leuk Lymphoma. 2024 Feb 21:1-6. doi: 10.1080/10428194.2024.2317343.
PubMed
Abstract available
Australian experience with ibrutinib in patients with relapsed/refractory mantle
cell lymphoma: a study from the Lymphoma and Related Diseases Registry.
Leuk Lymphoma. 2023;64:621-627.
PubMed
Abstract available
A pediatric case of KMT2A-rearranged B-lymphoblastic lymphoma treated with
high-risk therapy.
Leuk Lymphoma. 2024 Feb 19:1-5. doi: 10.1080/10428194.2024.2315159.
PubMed
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to
treat non-upper aerodigestive tract natural killer/T-cell lymphoma.
Leukemia. 2024 Feb 20. doi: 10.1038/s41375-024-02171.
PubMed
Abstract available
Late morbidity and mortality after autologous blood or marrow transplantation for
lymphoma in children, adolescents and young adults-a BMTSS report.
Leukemia. 2024 Feb 19. doi: 10.1038/s41375-024-02144.
PubMed
Abstract available
Thank you for your interest in scientific medicine.